Results 1 - 10 of 57
[PROJECT] EUROCANPLATFORM - A European Platform for Translational Cancer Research
ID: 260791
Start date: 2011-01-01, End date: 2016-12-31
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer r...
Programme: FP7-HEALTH
Record Number: 97701
Last updated on: 2017-05-29
[RESULT IN BRIEF] Hypoxie als therapeutischer Ansatz bei Tumorerkrankungen
Die Ursachen der Metastasierung von Tumoren zu klären, ist von zentraler Bedeutung für neue therapeutische Ansätze. Ein großes wissenschaftliches Konsortium beschäftigte sich hierfür mit dem Konzept der Hypoxie.
Programme: FP7-HEALTH
Record Number: 90303
Last updated on: 2015-07-30
[RESULT IN BRIEF] Targeting hypoxia to cure cancer
Understanding how tumours spread and generate metastases is central to therapy. A large consortium of European scientists focused on hypoxia for answers.
Programme: FP7-HEALTH
Record Number: 90303
Last updated on: 2015-07-30
[RESULT IN BRIEF] Tratamiento anticancerígeno dirigido a la hipoxia
Conocer los mecanismos de propagación y desarrollo de las metástasis resulta esencial para diseñar un tratamiento anticancerígeno eficaz. En un consorcio europeo tratan de identificar soluciones mediante el estudio de los efectos de la hipoxia en el cáncer.
Programme: FP7-HEALTH
Record Number: 90303
Last updated on: 2015-07-30
[RESULT IN BRIEF] Cibler l'hypoxie pour soigner le cancer
Comprendre comment les tumeurs se propagent et génèrent des métastases est capital pour la thérapie. Un grand consortium de scientifiques européens s'est tourné vers l'hypoxie pour trouver des réponses.
Programme: FP7-HEALTH
Record Number: 90303
Last updated on: 2015-07-30
[RESULT IN BRIEF] L’ipossia come obiettivo per curare il cancro
Riuscire a comprendere in che modo avviene la diffusione dei tumori e l’insorgenza delle metastasi è un problema fondamentale per la terapia oncologica. Un grande consorzio di scienziati europei ha concentrato la sua attenzione sull’ipossia.
Programme: FP7-HEALTH
Record Number: 90303
Last updated on: 2015-07-30
[PROJECT] METOXIA - Metastatic tumours facilitated by hypoxic tumour micro-environments
ID: 222741
Start date: 2009-02-01, End date: 2014-07-31
Recent research suggests that the hypoxic micro-environment of tumours is one of the major drivers of metastatic spread of cancer. Furthermore, hypoxic tumour micro-environments may result in treatment resistance of cancer cells, therefore causing a double effect of reducing ...
Programme: FP7-HEALTH
Record Number: 91061
Last updated on: 2017-07-12
[RESULT IN BRIEF] Celowanie w hipoksję w walce z rakiem
Zrozumienie, w jaki sposób guzy rozprzestrzeniają się i tworzą przerzuty, ma kluczowe znaczenie dla możliwości leczenia raka. Duże europejskie konsorcjum naukowe zajęło się hipoksją, poszukując informacji na ten temat.
Programme: FP7-HEALTH
Record Number: 90303
Last updated on: 2015-07-30
[REPORT SUMMARY] Final Report Summary - METOXIA (Metastatic tumours facilitated by hypoxic tumour micro-environments)
Executive Summary:The METOXIA consortium answered a call which was ambitious, aiming to translate knowledge on the molecular machinery responsible for survival and spread of metastatic tumour cells under hypoxic conditions into innovative and validated molecular targets with...
Programme: FP7-HEALTH
Record Number: 159277
Last updated on: 2015-04-07
[PROJECT] STOPENTERICS - Vaccination against Shigella and ETEC: novel antigens, novel approaches
ID: 261472
Start date: 2010-11-01, End date: 2017-12-31
To contribute to the development of vaccines against Shigella and ETEC for children of the developing world, STOPENTERICS will provide novel solutions by imposing a two-fold paradigm switch: (i) to break the dogma of serotype-specificity by inducing a cross-protective immunit...
Programme: FP7-HEALTH
Record Number: 97173
Last updated on: 2017-07-02
List retrieved on: 2017-08-02
